Julien Guérin

563 total citations
26 papers, 178 citations indexed

About

Julien Guérin is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Julien Guérin has authored 26 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Julien Guérin's work include Breast Cancer Treatment Studies (6 papers), Cancer Risks and Factors (3 papers) and Advancements in Semiconductor Devices and Circuit Design (3 papers). Julien Guérin is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Cancer Risks and Factors (3 papers) and Advancements in Semiconductor Devices and Circuit Design (3 papers). Julien Guérin collaborates with scholars based in France, Switzerland and Hungary. Julien Guérin's co-authors include Anne‐Sophie Hamy, Florence Coussy, Enora Laas, Fabien Reyal, Jean‐Yves Pierga, Marick Laé, Jean-Guillaume Féron, A Gouazé, G Lazorthes and Roman Rouzier and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

Julien Guérin

23 papers receiving 168 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julien Guérin France 7 69 60 32 29 28 26 178
Elizabeth Blessing Elimimian United States 9 44 0.6× 101 1.7× 31 1.0× 11 0.4× 43 1.5× 20 199
Danny Jazmati Germany 7 36 0.5× 19 0.3× 23 0.7× 19 0.7× 33 1.2× 23 108
M. Sattler Netherlands 10 70 1.0× 25 0.4× 18 0.6× 69 2.4× 51 1.8× 21 300
Devrim Çabuk Türkiye 9 37 0.5× 79 1.3× 18 0.6× 18 0.6× 45 1.6× 37 191
M. Piccart Belgium 9 89 1.3× 167 2.8× 19 0.6× 19 0.7× 55 2.0× 34 286
Daniela Bossi Italy 10 137 2.0× 56 0.9× 102 3.2× 40 1.4× 23 0.8× 19 303
R. Gunapala United Kingdom 10 32 0.5× 66 1.1× 12 0.4× 41 1.4× 177 6.3× 20 290
Mari Ichikawa Japan 9 79 1.1× 54 0.9× 50 1.6× 12 0.4× 18 0.6× 19 234
Jose Bonilla Spain 6 71 1.0× 85 1.4× 28 0.9× 25 0.9× 71 2.5× 17 310
E. Giralt Spain 7 76 1.1× 52 0.9× 43 1.3× 8 0.3× 39 1.4× 12 295

Countries citing papers authored by Julien Guérin

Since Specialization
Citations

This map shows the geographic impact of Julien Guérin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julien Guérin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julien Guérin more than expected).

Fields of papers citing papers by Julien Guérin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julien Guérin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julien Guérin. The network helps show where Julien Guérin may publish in the future.

Co-authorship network of co-authors of Julien Guérin

This figure shows the co-authorship network connecting the top 25 collaborators of Julien Guérin. A scholar is included among the top collaborators of Julien Guérin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julien Guérin. Julien Guérin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boutros, Michael, Michaël Baumann, Anna Bigas, et al.. (2024). UNCAN.eu: Toward a European Federated Cancer Research Data Hub. Cancer Discovery. 14(1). 30–35. 2 indexed citations
2.
Kempf, Emmanuelle, Damien Leprovost, Nicolas Griffon, et al.. (2023). How to Improve Cancer Patients ENrollment in Clinical Trials From rEal-Life Databases Using the Observational Medical Outcomes Partnership Oncology Extension: Results of the PENELOPE Initiative in Urologic Cancers. JCO Clinical Cancer Informatics. 7(7). e2200179–e2200179. 4 indexed citations
3.
Delrieu, Lidia, Anne‐Sophie Hamy, Florence Coussy, et al.. (2022). Digital phenotyping in young breast cancer patients treated with neoadjuvant chemotherapy (the NeoFit Trial): protocol for a national, multicenter single-arm trial. BMC Cancer. 22(1). 493–493. 3 indexed citations
4.
Guérin, Julien, Yec’han Laizet, Vincent Le Texier, et al.. (2021). OSIRIS: A Minimum Data Set for Data Sharing and Interoperability in Oncology. JCO Clinical Cancer Informatics. 5(5). 256–265. 18 indexed citations
5.
Laas, Enora, Julie Labrosse, Anne‐Sophie Hamy, et al.. (2021). Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore. British Journal of Cancer. 124(8). 1421–1427. 22 indexed citations
6.
Guérin, Julien, Enora Laas, Jean-Guillaume Féron, et al.. (2021). Breast Cancer (BC) Is a Window of Opportunity for Smoking Cessation: Results of a Retrospective Analysis of 1234 BC Survivors in Follow-Up Consultation. Cancers. 13(10). 2423–2423. 6 indexed citations
7.
8.
Laas, Enora, Julien Guérin, Jean‐Yves Pierga, et al.. (2020). No Impact of Smoking Status on Breast Cancer Tumor Infiltrating Lymphocytes, Response to Neoadjuvant Chemotherapy and Prognosis. Cancers. 12(10). 2943–2943. 4 indexed citations
9.
Labrosse, Julie, Marie Osdoit, Julien Guérin, et al.. (2019). Text Mining in Electronic Medical Records Enables Quick and Efficient Identification of Pregnancy Cases Occurring After Breast Cancer. JCO Clinical Cancer Informatics. 3(3). 1–12. 7 indexed citations
10.
Laroche, F., et al.. (2018). La fibromyalgie en France : vécu quotidien, fardeau professionnel et prise en charge. Enquête nationale auprès de 4516 patients. Revue du Rhumatisme. 86(1). 90–95. 5 indexed citations
11.
Laroche, F. & Julien Guérin. (2015). Fibromyalgie : où en est-on en 2015 ?. Douleur et Analgésie. 28(1). 31–39. 2 indexed citations
12.
Rostaing-Rigattieri, S. & Julien Guérin. (2014). Prise en charge des douleurs cancéreuses rebelles : stratégies pratiques. Médecine Palliative. 13(6). 312–322. 1 indexed citations
13.
Rostaing-Rigattieri, S. & Julien Guérin. (2013). Douleurs cancéreuses : bonnes pratiques cliniques de prise en charge, gestions des opioïdes forts. La Presse Médicale. 43(3). 252–262. 4 indexed citations
14.
Bliek, A., et al.. (2002). Modeling of IGBT Short-Circuit Behavior. physica status solidi (a). 194(1). 129–139.
15.
Boistel, J, E Coraboeuf, & Julien Guérin. (2002). [Peripheral nerves of insects; reaction of nerve fibers to carbon dioxide].. PubMed. 49(1). 53–6.
16.
Bliek, A., et al.. (1997). Le transistor VDMOS en régime de quasi-saturation : étude analytique et modélisation. Journal de Physique III. 7(9). 1851–1868. 3 indexed citations
17.
Bouvard, M., et al.. (1994). Etude de validation sur une population française de l'échelle d'attitudes dysfonctionnelles de Weissman et Beck (DAS forme A). Journal de Thérapie Comportementale et Cognitive. 4(4). 127–135. 8 indexed citations
18.
Darrouzet, Vincent, et al.. (1990). [Radiation-induced sarcoma, apropos of a case with cervical and intrapetrous development].. PubMed. 111(3). 247–50. 3 indexed citations
19.
Darrouzet, Vincent, et al.. (1990). [Irradiation of neurinoma. Why? How? First results].. PubMed. 111(3). 211–5. 1 indexed citations
20.
Guérin, Julien, et al.. (1981). [Response factors in the treatment of malignant gliomas in the adult (author's transl)].. PubMed. 27(5). 305–14. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026